Literature DB >> 35022349

Trans-arterial Embolization in a Patient with Unilateral Absence of Pulmonary Artery: Treatment Success and the Four-year Prognosis.

Yoshitaka Ono1, Kyoko Niimi1, Yukihiro Horio1, Takahisa Takihara1, Genki Takahashi1, Kazuki Harada1, Hiroto Takiguchi1, Katsuyoshi Tomomatsu1, Naoki Hayama1, Tsuyoshi Oguma1, Takuya Aoki1, Tetsuya Urano1, Tatsuya Sekiguchi2, Jun Koizumi2, Koichiro Asano1.   

Abstract

Unilateral absence of the pulmonary artery (UAPA) with or without other anomalies in the heart is a rare congenital malformation. A 55-year-old Filipino woman without a remarkable medical history was admitted to our hospital for hemoptysis. Contrast-enhanced chest computed tomography revealed the absence of the left pulmonary artery. Echocardiography and right heart catheterization showed no cardiac malformations or pulmonary hypertension. We diagnosed her with isolated left-sided UAPA and performed transarterial embolization of the left inferior phrenic artery. This resolved the hemoptysis, and there was no recurrence during the four-year follow-up period.

Entities:  

Keywords:  angiography; cardiovascular malformation; embolization; hemoptysis

Mesh:

Year:  2022        PMID: 35022349      PMCID: PMC9424082          DOI: 10.2169/internalmedicine.8667-21

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.282


Introduction

The prevalence of unilateral absence of pulmonary artery (UAPA) without associated cardiovascular anomalies, or isolated UAPA, ranges from 1 in 200,000 to 300,000 (1). In these cases, the blood supply to the lungs is through the systemic circulation, such as bronchial arteries, intercostal arteries, and internal thoracic arteries (2). Patients with isolated UAPA in adulthood are generally asymptomatic, although they may present with hemoptysis or repetitive respiratory infections that require specific treatments (3-6). However, there is limited information available on therapeutic approaches for isolated UAPA. We herein report the successful treatment of a patient presenting with hemoptysis due to isolated UAPA via transarterial embolization (TAE) of the collateral artery.

Case Report

A 55-year-old Filipino woman was admitted to the hospital because of bloody sputum and hemoptysis (blood loss of approximately 70 mL) in the past 2 weeks accompanied by persistent cough for 1 month. Except for untreated hypertension, she and her family had no history of cardiopulmonary diseases. Her blood pressure was 140/80 mmHg, heart rate was 92/min, respiratory rate was 18/min, and percutaneous oxygen saturation (SpO2) was 98% under room air breathing. The left rib cage was smaller than the right, and a physical examination revealed decreased breath sounds in the left chest. No crackles were heard in the bilateral lung fields. There were no abnormalities in the peripheral blood counts or results of coagulation or blood biochemical tests, including serum brain natriuretic peptide levels. On admission, chest radiography revealed a smaller size of the left lung than the right, with decreased permeability (Fig. 1A). Thoracic computed tomography (CT) revealed ground-glass opacity in the lingua of the left lung (Fig. 1B), and contrast-enhanced images demonstrated that the left pulmonary artery was absent (Fig. 1C). In addition, the left inferior phrenic artery and 6-9th intercostal arteries were dilated and tortuous, feeding on the left lower lobe of the lung (Fig. 1D, E). Selective angiography of the left inferior phrenic artery showed a contrasting effect on the left inferior lung field (Fig. 2A). Neither an early description of the pulmonary venous phase nor shunt formation was observed. Echocardiography and right heart catheterization revealed no cardiac malformations or pulmonary hypertension; the mean pulmonary arterial pressure was 21 mmHg, and the pulmonary vascular resistance was 130 dynes/s/cm-5. A bronchoscopic examination revealed no lesions that might be causing active bleeding. Therefore, we diagnosed this as a case of isolated left-sided UAPA, presuming the left inferior phrenic artery to be the vessel responsible for hemoptysis.
Figure 1.

Radiography findings on admission. Chest radiograph (A) showing decreased volume and permeability of the left lung. Chest CT (B, C) demonstrating ground-glass opacity in the lingua of the left lung and absence of the left pulmonary artery. Three-dimensional chest CT showing the dilated and tortuous left inferior phrenic artery (yellow arrow, D) and 6-9th intercostal arteries (yellow arrow heads, E), which are running into the left inferior lung field. CT: computed tomography

Figure 2.

Angiography before and after trans-arterial embolization. (A) Selective angiography for the left inferior phrenic artery showing a stain on the left inferior pulmonary field. (B) Following embolization of left inferior phrenic artery, the abnormal stain of the pulmonary field disappeared.

Radiography findings on admission. Chest radiograph (A) showing decreased volume and permeability of the left lung. Chest CT (B, C) demonstrating ground-glass opacity in the lingua of the left lung and absence of the left pulmonary artery. Three-dimensional chest CT showing the dilated and tortuous left inferior phrenic artery (yellow arrow, D) and 6-9th intercostal arteries (yellow arrow heads, E), which are running into the left inferior lung field. CT: computed tomography Angiography before and after trans-arterial embolization. (A) Selective angiography for the left inferior phrenic artery showing a stain on the left inferior pulmonary field. (B) Following embolization of left inferior phrenic artery, the abnormal stain of the pulmonary field disappeared. On day 3 of admission, TAE was performed using a gelatin sponge, which was prepared by cutting the sponge into 1-mm squares and mixing and crushing it in contrast medium via the pumping method (7-9). The contrast effect of the pulmonary field disappeared after the TAE of the left inferior phrenic artery (Fig. 2B). Her blood pressure was controlled with an oral calcium blocker. There were no episodes of hemoptysis or respiratory tract infections during the four-year period after TAE without further intervention on the left intercostal arteries.

Discussion

Isolated UAPA is often asymptomatic, but sometimes presents with hemoptysis or recurrent respiratory tract infections. Although surgical therapy, TAE, and hemostatic materials are often considered (10-14), there has been no established treatment for symptomatic isolated UAPA. In the present case, long-term control of hemoptysis was achieved using a single TAE procedure. There have been three reported cases of UAPA that achieved long-term control of hemoptysis with TAE: two men, 37 and 40 years old, who were treated with coil embolization (13), and a 31-year-old man for whom non-spherical polyvinyl alcohol particles were used for treatment (14). However, most patients with hemoptysis due to UAPA who are treated with TAE suffer relapse. According to a systemic review of 65 adult patients with isolated UAPA, TAE was performed in 6 patients, and 5 of them (83%) were eventually treated with pneumonectomy (4). These experiences suggest that treatment strategies for UAPA need to be developed with the understanding that there is a high risk of recurrence. To successfully treat UAPA with TAE, it is important to correctly identify the responsible artery. In the present case, both the left inferior phrenic artery and intercostal arteries were dilated on contrast-enhanced CT. We therefore planned a two-stage approach - first to the left inferior phrenic artery and then to the intercostal arteries - to minimize the risk for pulmonary infarction. As the hemoptysis was completely controlled with the first embolization of the left inferior phrenic artery, a further evaluation and embolization of the intercostal arteries were not performed. Although several materials have been used for vascular embolization, including gelatin sponge, coils, n-butyl cyanoacrylate, and polyvinyl alcohol particles, no consensus concerning the embolization materials has been reached. Coils are a powerful and permanent embolic material; however, embolization of the proximal arteries by coils may induce the development of a more distal and fragile collateral blood supply (15). N-butyl cyanoacrylate is also a permanent embolization material, but we avoided its use in this case because of the risk of infection that could have arisen due to tissue necrosis (16,17). Particulate embolic materials, such as gelatin sponge and polyvinyl alcohol particles, are useful in overcoming these drawbacks. Gelatin sponge particles injected through a catheter are carried distally via the arterial bloodstream and then trapped in the vessels where blood clotting gradually takes place under the blood flow blocked by mechanical obstruction. This hemostatic ability of the gelatin sponge is almost equivalent to that of the fibrin (18). Other reports suggest that embolization with a gelatin sponge may cause permanent blockage of blood vessels due to the development of granulomatous vasculitis-like lesions (19,20). However, temporary embolic materials have some disadvantages, such as the risk of reopening, which may lead to hemoptysis recurrence (21). In particular, when performing TAE with a gelatin sponge, it is difficult to gauge how far the catheter should be advanced toward the target and how small the embolic material should be split for administration. Thus far, the choice and use of embolic agents has been based on personal experience and expertise, with the understanding of the properties of each agent along with the anatomical and histological changes varying among cases (22).

Conclusion

We encountered a case of isolated left-sided UAPA that was successfully treated with selective TAE of the left inferior phrenic artery using a gelatin sponge, with the symptoms remaining under control for four years. There have only been a few reports concerning the long-term prognosis of UAPA after TAE, and further research is needed to establish the most appropriate treatment approach. The authors state that they have no Conflict of Interest (COI).
  22 in total

1.  [Rapid production of gelatin sponge particles for transcatheter arterial embolization: pumping method].

Authors:  H Mori; Y Saida; Y Watanabe; T Irie; Y Itai
Journal:  Nihon Igaku Hoshasen Gakkai Zasshi       Date:  2000-10

2.  Studies on the Use of Gelatin Sponge or Foam as an Hemostatic Agent in Experimental Liver Resections and Injuries to Large Veins.

Authors:  H P Jenkins; R Janda
Journal:  Ann Surg       Date:  1946-11       Impact factor: 12.969

3.  Cerebral N-butyl cyanoacrylate glue-induced abscess complicating embolization.

Authors:  Aadil S Chagla; Srikant Balasubramaniam
Journal:  J Neurosurg       Date:  2008-08       Impact factor: 5.115

Review 4.  Gelatine sponge particles: handling characteristics for endovascular use.

Authors:  Hicham T Abada; Jafar Golzarian
Journal:  Tech Vasc Interv Radiol       Date:  2007-12

Review 5.  Advances in Biomaterials and Technologies for Vascular Embolization.

Authors:  Jingjie Hu; Hassan Albadawi; Brian W Chong; Amy R Deipolyi; Rahul A Sheth; Ali Khademhosseini; Rahmi Oklu
Journal:  Adv Mater       Date:  2019-06-06       Impact factor: 30.849

6.  Pneumonectomy for congenital isolated unilateral pulmonary artery agenesis.

Authors:  J Britton; A Sachithanandan; L Srinivasan; S Ghosh
Journal:  Med J Malaysia       Date:  2011-10

Review 7.  Isolated unilateral absence of a pulmonary artery: a case report and review of the literature.

Authors:  A Derk Jan Ten Harkel; Nico A Blom; Jaap Ottenkamp
Journal:  Chest       Date:  2002-10       Impact factor: 9.410

8.  Comparison of the effectiveness of embolic agents for bronchial artery embolization: gelfoam versus polyvinyl alcohol.

Authors:  Seok Hahn; Young Ju Kim; Woocheol Kwon; Seung-Whan Cha; Won-Yeon Lee
Journal:  Korean J Radiol       Date:  2010-08-27       Impact factor: 3.500

Review 9.  Unilateral absence of pulmonary artery: pathophysiology, symptoms, diagnosis and current treatment.

Authors:  Peter Kruzliak; Rao P Syamasundar; Miroslav Novak; Olga Pechanova; Gabriela Kovacova
Journal:  Arch Cardiovasc Dis       Date:  2013-08-09       Impact factor: 2.340

10.  The varied manifestation of pulmonary artery agenesis in adulthood.

Authors:  D Bouros; P Pare; P Panagou; K Tsintiris; N Siafakas
Journal:  Chest       Date:  1995-09       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.